These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3566442)

  • 1. [Cardiovascular and digestive effects of 2 mydriatics in the low-birth-weight newborn infant].
    Walti H; Daoud P; Broussin B; Ryzman P; Moriette G; Relier JP
    Arch Fr Pediatr; 1987 Jan; 44(1):31-3. PubMed ID: 3566442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased blood pressure following pupillary dilation with 2.5% phenylephrine hydrochloride in preterm infants.
    Lees BJ; Cabal LA
    Pediatrics; 1981 Aug; 68(2):231-4. PubMed ID: 7267230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of systemic administration of 0.5% tropicamide on intraocular pressure, pupillary diameter, blood pressure, and heart rate in normal cats.
    Schmidt KS; Hacker DV; Kass PH; Barkhoodarian AL
    Vet Ophthalmol; 2006; 9(2):137-9. PubMed ID: 16497239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
    Stadtbäumer K; Frommlet F; Nell B
    Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%.
    Motta MM; Coblentz J; Fernandes BF; Burnier MN
    Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic effects of mydriatics in low weight infants.
    Rosales T; Isenberg S; Leake R; Everett S
    J Pediatr Ophthalmol Strabismus; 1981; 18(6):42-4. PubMed ID: 7334446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial.
    Pellicer A; Valverde E; Elorza MD; Madero R; Gayá F; Quero J; Cabañas F
    Pediatrics; 2005 Jun; 115(6):1501-12. PubMed ID: 15930210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes.
    Valverde E; Pellicer A; Madero R; Elorza D; Quero J; Cabañas F
    Pediatrics; 2006 Jun; 117(6):e1213-22. PubMed ID: 16717120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of a new ophthalmic mydriatic insert in healthy volunteers: potential alternative as drug delivery system prior to cataract surgery.
    Mouly S; Mahé I; Haouchine B; Sanson-le-Pors MJ; Blain P; Tillet Y; Dewailly J; Mongold JJ; Bergmann JF
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):547-54. PubMed ID: 16700815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of mydriatics in low-birth-weight infants.
    Isenberg S; Everett S
    J Pediatr; 1984 Jul; 105(1):111-2. PubMed ID: 6737125
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children.
    Ebri A; Kuper H; Wedner S
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1025-31. PubMed ID: 17325142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mydriatic eye drops: severe adverse effects in children. Systemic reactions.
    Prescrire Int; 2009 Jun; 18(101):123. PubMed ID: 19637434
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of atropine and tropicamide in esotropia.
    Hiatt RL; Jerkins G
    Ann Ophthalmol; 1983 Apr; 15(4):341-3. PubMed ID: 6660705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does prior instillation of a topical anaesthetic alter the pupillary mydriasis produced by tropicamide (0.5%)?
    Haddad DE; Rosenfield M; Portello JK; Krumholz DM
    Ophthalmic Physiol Opt; 2007 May; 27(3):311-4. PubMed ID: 17470245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilation in neonates: a protocol.
    Caputo AR; Schnitzer RE; Lindquist TD; Sun S
    Pediatrics; 1982 Jan; 69(1):77-80. PubMed ID: 7054765
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of potentiating effect of a drop of lignocaine on tropicamide-induced mydriasis.
    Ghose S; Garodia VK; Sachdev MS; Kumar H; Biswas NR; Pandey RM
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1581-5. PubMed ID: 11381064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind study of phenylephrine 2.5% vs 10% on pupillary dilation.
    Yospaiboon Y; Luanratanakorn P; Noppawinyoowong C
    J Med Assoc Thai; 2004 Nov; 87(11):1380-4. PubMed ID: 15825717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy and tolerance between 1% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) and 0.5% tropicamide combined with 2.5% phenylephrine.
    Zeise MM; McDougall BW; Bartlett JD; Corliss D; Mitten L
    J Am Optom Assoc; 1996 Nov; 67(11):681-9. PubMed ID: 8979662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atropine versus cyclopentolate plus tropicamide in esodeviations.
    Goldstein JH; Schneekloth BB
    Ophthalmic Surg Lasers; 1996 Dec; 27(12):1030-4. PubMed ID: 8976523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pupillary dilation and funduscopy with 1.0% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) versus tropicamide (0.5 or 1.0%) as a function of iris and skin pigmentation, and age.
    Cooper J; Feldman JM; Jaanus SD; Appleman W; Appel S; Horn D
    J Am Optom Assoc; 1996 Nov; 67(11):669-75. PubMed ID: 8979660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.